Research Use Only. Not for human or veterinary use.
Nexaflow Research
Vial of lyophilised Ipamorelin, 5 mg

Ipamorelin

A synthetic pentapeptide and selective agonist of the growth hormone secretagogue receptor.

Investigated in preclinical models of ghrelin receptor signalling and gastrointestinal motility.

Research Use Only. Not for human or veterinary use.

These materials are supplied to laboratories and research organisations as reagents. They are not medicines, are not supplied for administration to humans or animals, and must not be resold for those purposes.

In stock · lot A2926037 · 99.94% purity by HPLC · view certificate

Dispatched within 2 working days · tracked UK delivery · no account needed

£19.99£15.99 · £3.20/mg

Specification

Molecular formula
C38H49N9O5
Molecular weight
711.9 g/mol
Sequence
Aib-His-D-2Nal-D-Phe-Lys-NH25 residues
Purity
≥98% (HPLC)
Appearance
White lyophilised powder
Storage
Store at -20°C, protected from light and moisture.

Standard specification for this compound. The values measured for each lot are on its certificate of analysis.

In the literature

  1. Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review

    Vasylieva V, et al · Sexual medicine reviews · 2026

    PMID 42862021doi:10.1093/sxmrev/qeag078

  2. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

    Dominikowski A, et al · Frontiers in endocrinology · 2026

    PMID 42395176doi:10.3389/fendo.2026.1822475

  3. Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives

    Renke G, Chinellato L · International journal of molecular sciences · 2026

    PMID 42123471doi:10.3390/ijms27093890

  4. Therapeutic peptides in gerontology: mechanisms and applications for healthy aging

    Mavrych V, et al · Frontiers in aging · 2026

    PMID 42021992doi:10.3389/fragi.2026.1790247

  5. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance

    Mendias CL, Awan TM · Sports medicine (Auckland, N.Z.) · 2026

    PMID 41966639doi:10.1007/s40279-026-02437-0

Follow new lots on Telegram

New lot releases, each certificate as it arrives, and restock updates, posted first on Telegram.

Join on Telegram